申请人:Allergan, Inc.
公开号:US20150336940A1
公开(公告)日:2015-11-26
Disclosed herein are compounds of the formula:
compositions thereof, and methods for the treatment of glaucoma, reducing intraocular pressure, and other prostaglandin EP
2
mediated disease and disorders.
本文披露了以下公式的化合物:其组合物以及治疗青光眼、降低眼内压和其他前列腺素EP2介导的疾病和紊乱的方法。